According to the DSM-IV, Social Phobia is a marked or persistent fear of embarrassment or humiliation in one or more social or performance situations, in which the person is exposed to unfamiliar people or to possible scrutiny by others. The fear or avoidance is not better accounted by for by another disorder (Eg., Panic Disorder, Separation Anxiety Disorder, Body Dysmorphic Disorder, or Schizoid Personality Disorder). (DSM-IV)
There are several subtypes of social phobia, including. Generalized social phobia is referred to as GSP, but there are specific types as well.
The Institute treats social phobia using 'in vivo' exposures in Exposure Response Prevention Therapy, and will involve walking around the UCLA campus and/or Westwood area and seeking interactions with others. A cognitive component will be implemented through talk therapy and extensive writing exercises, and we may utilize other methods to customize treatment for the individual patient.
Source: Page 400, DSM-IV, Year 2005, American Psychiatric Association
Dr. Gorbis will be lecturing on the "Comorbidity of OCD and Eating Disorders and its Implication to Treatment" to members of the LA County Psychological Association. She will be addressing the issue of comorbidity of OCD and eating disorders and the implications of each disorders in terms of etiology as well as treatment.
Dr. Eda Gorbis was featured in MTV's show, "TrueLife", a powerful, award-winning series that uniquely reflects the experiences and cultures of this generation.This episode documents the unusual—and often remarkable circumstances of real individuals with Body Dysmorphic Disorder.
Learn more about Body Dysmorphic Disorder on our blog.
To pre-qualify for this study, patients must be at least 18 yrs. old, have a documented diagnosis of OCD as defined by the DSM-IV-TR, have been taking one of the following SSRIs for at least six weeks prior to screening and at the minimum daily dosage listed: fuvoxamine (Luvox®) 200 mg, fluoxetine (Prozac®) 40 mg, paroxetine (Paxil®) 40 mg, sertraline (Zoloft®) 100 mg. The study is expected to last about 20 weeks. Each patient will receive study medication and study-related medical evaluations at no cost. Reimbursement for travel may also be provided. Please contact us for additional eligibility requirements.
Dr. Gorbis talks about Body Dysmorphic order, its successful treatment methods, and resources for therapists. Watch it now at http://www.psychotherapy.net/interview/eda-gorbis-body-dysmorphic.